ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Reductil® 10/15:Abbott AG
Information professionnelle complèteDDDimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
TitulaireMise à jour 
A08AA10 - SibutramineATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A08 - Antiobesity Preparations, Excl. Diet Products
 
A08A - Antiobesity Preparations, Excl. Diet Products

Low-energy diets, see V06AA.

A08AA - Centrally Acting Antiobesity Products

Amfetamine, which is commonly used in psychiatry, is classified in N06B - Psychostimulants, agents used for ADHD and nootropics.
Fenfluramine indicated for the treatment of seizures associated with Dravet syndrome is classified in N03AX - Other antiepileptics.

A08AA10 - Sibutramine
Concentr.Adm.RouteNote
 O 
2025 ©ywesee GmbH
Einstellungen | Aide | Identification | Contact | Home